Herpes neolabialis: herpes simplex virus type 1 infection of the neolabia in a transgender woman
- PMID: 28632111
- DOI: 10.1177/0956462416685658
Herpes neolabialis: herpes simplex virus type 1 infection of the neolabia in a transgender woman
Abstract
A 24-year-old transgender woman consulted our outpatient clinic with a painful, itchy and red left labia. She underwent a penile inversion vaginoplasty 18 months before presentation. At physical examination of the left labia, erythema, edema and herpetic vesicles with ulceration were observed. A vesicle fluid swab was obtained and the presence of herpes simplex virus type 1 (HSV-1) was detected by PCR assay. Treatment consisted of oral valaciclovir (500 mg twice daily) for a total of five days.Topically-applied lidocaine cream (3%) was used for pain management. Treatment gave symptom relief in five days. At physical examination 14 days after symptom onset, there were no signs of active infection. To our knowledge, this is the first case report of HSV-1 infection of the neolabia in a transgender woman.
Keywords: Herpes simplex; gender dysphoria; herpes labialis; sex reassignment procedures; sexual behavior; sexually transmitted infection; vaginoplasty.
Similar articles
-
ACOG practice bulletin: Clinical management guidelines for obstetrician-gynecologists, number 57, November 2004. Gynecologic herpes simplex virus infections.Obstet Gynecol. 2004 Nov;104(5 Pt 1):1111-8. Obstet Gynecol. 2004. PMID: 15516420
-
A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis. Valaciclovir HSV Study Group.Arch Intern Med. 1996 Aug 12-26;156(15):1729-35. Arch Intern Med. 1996. PMID: 8694673 Clinical Trial.
-
Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years' experience with acyclovir.J Infect Dis. 2002 Oct 15;186 Suppl 1:S40-6. doi: 10.1086/342966. J Infect Dis. 2002. PMID: 12353186 Review.
-
Valaciclovir versus aciclovir for herpes simplex virus infection in HIV-infected individuals: two randomized trials.Int J STD AIDS. 2002 Jan;13(1):12-21. doi: 10.1258/0956462021924550. Int J STD AIDS. 2002. PMID: 11802924 Clinical Trial.
-
Prevention of herpes simplex virus type 2 transmission with antiviral therapy.Herpes. 2004 Aug;11 Suppl 3:170A-174A. Herpes. 2004. PMID: 15319087 Review.
Cited by
-
Sexually Transmitted Infections Treatment Guidelines, 2021.MMWR Recomm Rep. 2021 Jul 23;70(4):1-187. doi: 10.15585/mmwr.rr7004a1. MMWR Recomm Rep. 2021. PMID: 34292926 Free PMC article.
-
Chlamydia trachomatis Infection of the Neovagina in Transgender Women.Open Forum Infect Dis. 2019 Nov 11;6(11):ofz470. doi: 10.1093/ofid/ofz470. eCollection 2019 Nov. Open Forum Infect Dis. 2019. PMID: 32395566 Free PMC article.
-
PATTERN OF PRESENTATION OF ORAL ULCERATIONS IN PATIENTS ATTENDING AN ORAL MEDICINE CLINIC IN NIGERIA.Ann Ib Postgrad Med. 2018 Jun;16(1):9-11. Ann Ib Postgrad Med. 2018. PMID: 30254553 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
